Actively Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
Led by GentiBio, Inc · Updated on 2026-05-06
200
Participants Needed
5
Research Sites
90 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
CONDITIONS
Official Title
HLA Demographics Study in Adults With Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female participants aged 18 to 55 years with type 1 diabetes meeting American Diabetes Association criteria at diagnosis
- Diagnosis of type 1 diabetes within 6 months of the study visit
- Able and willing to provide written informed consent themselves
You will not qualify if you...
- Employed by or immediate family member of an employee involved with the study sponsor, site, or contractor
- Unwilling or unable to comply with study visit assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
University of California, San Francisco
San Francisco, California, United States, 94158
Actively Recruiting
2
University of Florida- Gainesville
Gainesville, Florida, United States, 32610
Actively Recruiting
3
Joslin Diabetes Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
4
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
5
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27514
Actively Recruiting
Research Team
K
Kristin M Neff, MS
CONTACT
M
Mark Bach, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here